LIVERFASt-LFS NIT for Fatty Liver Disease, for Primary Care Provider (PCP) screening easlfibronostg on June 26, 2026 Category: Publications Tag: LIVERFASt, MASLD, NAFLD, Screening Post navigation Previous: Previous post: Assessment of Fatty Liver Disease using LIVERFASt in South-East Asia (real-world evidence)Next: Next post: Fasting vs non-fasting: assessment of the impact on LIVERSTAT
